CYTK
Price
$34.25
Change
+$0.89 (+2.67%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
4.09B
22 days until earnings call
MRUS
Price
$52.33
Change
-$0.25 (-0.48%)
Updated
Jul 8 closing price
Capitalization
3.9B
22 days until earnings call
Interact to see
Advertisement

CYTK vs MRUS

Header iconCYTK vs MRUS Comparison
Open Charts CYTK vs MRUSBanner chart's image
Cytokinetics
Price$34.25
Change+$0.89 (+2.67%)
Volume$51.23K
Capitalization4.09B
Merus
Price$52.33
Change-$0.25 (-0.48%)
Volume$451K
Capitalization3.9B
CYTK vs MRUS Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. MRUS commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and MRUS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (CYTK: $34.25 vs. MRUS: $52.33)
Brand notoriety: CYTK and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 89% vs. MRUS: 35%
Market capitalization -- CYTK: $4.09B vs. MRUS: $3.9B
CYTK [@Biotechnology] is valued at $4.09B. MRUS’s [@Biotechnology] market capitalization is $3.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than CYTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while MRUS’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 4 bearish.
  • MRUS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MRUS is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а +1.81% price change this week, while MRUS (@Biotechnology) price change was -0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

CYTK is expected to report earnings on Oct 30, 2025.

MRUS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.09B) and MRUS($3.9B) have the same market capitalization . MRUS YTD gains are higher at: 24.447 vs. CYTK (-27.190). MRUS has higher annual earnings (EBITDA): -298.55M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. MRUS (458M). MRUS has less debt than CYTK: MRUS (9.86M) vs CYTK (791M). MRUS has higher revenues than CYTK: MRUS (54.7M) vs CYTK (19.2M).
CYTKMRUSCYTK / MRUS
Capitalization4.09B3.9B105%
EBITDA-513.62M-298.55M172%
Gain YTD-27.19024.447-111%
P/E RatioN/AN/A-
Revenue19.2M54.7M35%
Total Cash938M458M205%
Total Debt791M9.86M8,026%
FUNDAMENTALS RATINGS
CYTK vs MRUS: Fundamental Ratings
CYTK
MRUS
OUTLOOK RATING
1..100
1457
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
8429
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6445
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MRUS's Valuation (60) in the Biotechnology industry is somewhat better than the same rating for CYTK (100). This means that MRUS’s stock grew somewhat faster than CYTK’s over the last 12 months.

MRUS's Profit vs Risk Rating (29) in the Biotechnology industry is somewhat better than the same rating for CYTK (84). This means that MRUS’s stock grew somewhat faster than CYTK’s over the last 12 months.

MRUS's SMR Rating (97) in the Biotechnology industry is in the same range as CYTK (100). This means that MRUS’s stock grew similarly to CYTK’s over the last 12 months.

MRUS's Price Growth Rating (45) in the Biotechnology industry is in the same range as CYTK (64). This means that MRUS’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for MRUS (100). This means that CYTK’s stock grew significantly faster than MRUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKMRUS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
78%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVSX17.590.14
+0.80%
MFS New Discovery Value R2
MMPDX33.480.10
+0.30%
NYLI WMC Value Class R6
FDYZX198.75N/A
N/A
Franklin DynaTech Adv
MCEMX14.23N/A
N/A
Martin Currie Emerging Markets IS
ESCFX14.08N/A
N/A
1290 Essex Small Cap Growth A

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IMVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
+2.67%
IMVT - CYTK
49%
Loosely correlated
+2.86%
IDYA - CYTK
49%
Loosely correlated
+1.37%
KRYS - CYTK
46%
Loosely correlated
+2.57%
BEAM - CYTK
45%
Loosely correlated
+5.84%
ROIV - CYTK
44%
Loosely correlated
+1.12%
More